Colon Cancer
ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer - CA266-0003
- Details
ClinicalTrials.gov ID:
NCT07221357
Diagnosis Type:
NA
USOR Number:
- Address
,
P: